Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Current Deferred Tax Assets (2010 - 2016)

Updated

Sinovac Biotech's Current Deferred Tax Assets was $3.49 million in Q4 2016, up 34.2% from $2.6 million a year earlier.

Analysis

Sinovac Biotech (SVA) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends

From Q4 2010 onward, Sinovac Biotech has reported Current Deferred Tax Assets for 5 quarters.

  • Current Deferred Tax Assets shows a three-year compound annual growth rate of 10.3% (FY2013 to FY2016).
  • In earlier years, Current Deferred Tax Assets was $2.6 million in FY2015 (+14.9%), $2.27 million in FY2014 (-12.9%) and $2.6 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 3.49 Mn
Dec 31, 2015 2.60 Mn
Dec 31, 2014 2.27 Mn
Dec 31, 2013 2.60 Mn
Dec 31, 2010 2.68 Mn
API Access

Sinovac Biotech Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=SVA&period=max&api_key=YOUR_API_KEY